Doliba N M, Babsky A M, Wehrli S L, Ivanics T M, Friedman M F, Osbakken M D
Biochemistry/Biophysics Department, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Biochemistry (Mosc). 2000 Apr;65(4):502-8.
Diabetic and control cardiomyocytes encapsulated in agarose beads and superfused with modified medium 199 were studied with 23Na- and 31P-NMR. Baseline intracellular Na+ was higher in diabetic (0.076 +/- 0.01 micromoles/mg protein) than in control (0.04 +/- 0.01 micromoles/mg protein) (p < 0.05). Baseline betaATP and phosphocreatine (PCr) (peak area divided by the peak area of the standard, methylene diphosphonate) were lower in diabetic than in control, e.g., betaATP control, 0.70 +/- 0.07; betaATP diabetic, 0. 49 +/- 0.04 (p < 0.027); PCr control, 1.20 +/- 0.13; PCr diabetic, 0. 83 +/- 0.11 (p < 0.03). This suggests that diabetic cardiomyocytes have depressed bioenergetic function, which may contribute to abnormal Na,K-ATPase function, and thus, an increase in intracellular Na+. In the experiments presented herein, three interventions (2-deoxyglucose, dinitrophenol, or ouabain infusions) were used to determine whether, and the extent to which, energy deficits or abnormalities in Na,K-ATPase function contribute to the increase in intracellular Na+. In diabetic cardiomyocytes, 2-deoxyglucose and ouabain had minimal effect on intracellular Na+, suggesting baseline depression of, or resetting of both glycolytic and Na,K-ATPase function, whereas in control both agents caused significant increases in intracellular Na+after 63 min exposure: 2-deoxyglucose control, 32.9 +/- 8.1%; 2-deoxyglucose diabetic, -4.6 +/- 6% (p < 0.05); ouabain control, 50.5 +/- 8.8%; ouabain diabetic, 21.2 +/- 9.2% (p < 0.05). In both animal models, dinitrophenol was associated with large increases in intracellular Na+: control, 119.0 +/- 26.9%; diabetic, 138.2 +/- 12.6%. Except for the dinitrophenol intervention, where betaATP and PCr decreased to levels below 31P-NMR detection, the energetic metabolites were not lowered to levels that would compromise sarcolemmal function (Na,K-ATPase) in either control or diabetic cardiomyocytes. In conclusion, in diabetic cardiomyocytes, even though abnormal glycolytic and Na, K-ATPase function was associated with increases in intracellular Na+, these increases were not directly related to global energy deficit.
将包裹在琼脂糖珠中并用改良培养基199进行灌流的糖尿病和对照心肌细胞,用23Na-和31P-NMR进行了研究。糖尿病心肌细胞的基线细胞内Na+(0.076±0.01微摩尔/毫克蛋白)高于对照心肌细胞(0.04±0.01微摩尔/毫克蛋白)(p<0.05)。糖尿病心肌细胞的基线βATP和磷酸肌酸(PCr)(峰面积除以标准品亚甲基二膦酸的峰面积)低于对照心肌细胞,例如,βATP对照为0.70±0.07;βATP糖尿病为0.49±0.04(p<0.027);PCr对照为1.20±0.13;PCr糖尿病为0.83±0.11(p<0.03)。这表明糖尿病心肌细胞的生物能功能受到抑制,这可能导致Na,K-ATP酶功能异常,进而导致细胞内Na+增加。在本文介绍的实验中,采用了三种干预措施(2-脱氧葡萄糖、二硝基苯酚或哇巴因输注)来确定能量缺乏或Na,K-ATP酶功能异常是否以及在多大程度上导致细胞内Na+增加。在糖尿病心肌细胞中,2-脱氧葡萄糖和哇巴因对细胞内Na+的影响最小,表明糖酵解和Na,K-ATP酶功能的基线受到抑制或重置,而在对照心肌细胞中,两种药物在暴露63分钟后均导致细胞内Na+显著增加:2-脱氧葡萄糖对照为32.9±8.1%;2-脱氧葡萄糖糖尿病为-4.6±6%(p<0.05);哇巴因对照为50.5±8.8%;哇巴因糖尿病为21.2±9.2%(p<0.05)。在两种动物模型中,二硝基苯酚均与细胞内Na+的大幅增加有关:对照为119.0±26.9%;糖尿病为138.2±12.6%。除二硝基苯酚干预使βATP和PCr降至低于31P-NMR检测水平外,能量代谢物在对照或糖尿病心肌细胞中均未降至会损害肌膜功能(Na,K-ATP酶)的水平。总之,在糖尿病心肌细胞中,尽管糖酵解和Na,K-ATP酶功能异常与细胞内Na+增加有关,但这些增加与整体能量缺乏并无直接关系。